TipRanks
Go Ultimate55% OFF

Bolt Biotherapeutics (BOLT) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

BOLT Analyst Ratings

Hold
1Ratings
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to Bolt Biotherapeutics in the past 3 months

BOLT Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for BOLT
Price TargetFollowArticle
JonesTrading―hold―Reiterated08/12/26
H.C. Wainwright$7buy6.22%UpsideReiterated05/28/26
Rodman & Renshaw$22buy233.84%UpsideInitiated05/28/26
Lake Street$75buy1038.09%UpsideReiterated05/13/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bolt Biotherapeutics

3 Months
Robert Burns
Robert BurnsH.C. Wainwright
Success Rate3/4 ratings generated profit
75%
Average Return
+1.45%

Copying Robert Burns's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +1.45% per trade.

1 Year
Robert Burns
Robert BurnsH.C. Wainwright
Success Rate3/4 ratings generated profit
75%
Average Return
+28.13%

Copying Robert Burns's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +28.13% per trade.

2 Years
Robert Burns
Robert BurnsH.C. Wainwright
Success Rate4/4 ratings generated profit
100%
Average Return
+37.82%

Copying Robert Burns's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +37.82% per trade.

BOLT Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for BOLT
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy20000
Buy10000
Hold22110
Sell00000
Strong Sell00000
total52110

In the current month, BOLT has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BOLT average Analyst price target in the past 3 months is ―.

BOLT Financial Forecast

$-6$-5$-4$-3$-2Q4 2025Q2 2026Q3 2026
High$-2.72
Consensus$-3.69
Low$-4.65

BOLT Earnings Forecast

Next quarter’s earnings estimate for BOLT is -$3.69 with a range of -$4.65 to -$2.72. The previous quarter’s EPS was -$4.57. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$624,999.5$1.3M$1.9M$2.5MQ4 2025Q2 2026Q3 2026
High$900K
Consensus$450K
Low$0.00

BOLT Sales Forecast

Next quarter’s sales forecast for BOLT is $450.00K with a range of $0 to $900.00K. The previous quarter’s sales results were $5,000. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

BOLT Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BOLT a Buy, Sell or Hold?
Bolt Biotherapeutics has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What do analysts say about Bolt Biotherapeutics?
Bolt Biotherapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of BOLT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.